The Hill quoted HIA in it’s article on the DEA extending COVID tele-prescribing rules through the end of 2024.
But the Health Innovation Alliance, a health technology advocacy group that represents providers, insurers, patients and others, said the DEA is needlessly delaying the inevitable.
“While this extension will help millions of Americans access much-needed medications, an extension is not a permanent rule,” the organization said in a statement. “The DEA needs to stop dragging its feet, admit that tele-prescribing is a success, and trust in the medical professionals who are treating patients.”